🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rupa Patel

Centers for Disease Control and Prevention

ORCID: 0000-0002-0329-7036

Also affiliated with Whitman-Walker Health

MedicineSocial SciencesHealth ProfessionsImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions”.

Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions

AIDS and Behavior(2020)10.1007/s10461-020-02820-6
N/A
0.646DataRank · unranked
73 citations

Sarah Wiatrek, Farah Mouhanna, K. Rivet Amico, Karen Dominguez, Jeb Jones +4 more

Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention

The Lancet HIV(2020)10.1016/s2352-3018(20)30256-3
N/A
0DataRank · unranked
55 citations

Rupa Patel, John A. Schneider, Dawn K. Smith, Sarah E. Rowan

False information on PrEP in direct-to-consumer advertising

The Lancet HIV(2020)10.1016/s2352-3018(20)30034-5
N/A
0DataRank · unranked
6 citations

William C. Goedel, Courtney E. Gomillia, Cassandra Sutten Coats, Rupa Patel, Matthew Murphy +4 more

Low Knowledge of HIV PrEP Within a Midwestern US Cohort of Persons who Inject Drugs

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab541
N/A
0DataRank · unranked
8 citations

Laura R. Marks, Rupa Patel, Nathanial S Nolan, Stephen Y. Liang, Michael J. Durkin +1 more

PrEP Persistence Support and Monitoring in Areas of High HIV Burden in the Midwestern United States

AIDS Education and Prevention(2023)10.1521/aeap.2023.35.3.235
N/A
0DataRank · unranked
2 citations

Jared Kerman, Samantha A. Devlin, Maria Pyra, Laura Rusie, Kate Curoe +8 more

Why is roll-out of long-acting PrEP agents so slow?

Current Opinion in HIV and AIDS(2024)10.1097/coh.0000000000000899
N/A
0DataRank · unranked
18 citations

Kenneth H. Mayer, Rupa Patel

First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae468
N/A
0DataRank · unranked
9 citations

Monica Gandhi, Elias K. Halvas, Hideaki Okochi, Carolyn Chu, David V. Glidden +18 more

Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure Prophylaxis

Clinical Infectious Diseases(2025)10.1093/cid/ciaf173
N/A
0DataRank · unranked
7 citations

Kevin P. Delaney, Ya-Lin A. Huang, Rupa Patel, Athena P. Kourtis, Karen W. Hoover +1 more

Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study—United States, 2019–2023

Clinical Infectious Diseases(2025)10.1093/cid/ciaf230
N/A
0DataRank · unranked
2 citations

Kevin P. Delaney, Ya-Lin A. Huang, Rupa Patel, Athena P. Kourtis, Karen W. Hoover +1 more

Longer-acting preexposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment

AIDS(2025)10.1097/qad.0000000000004247
N/A
0DataRank · unranked
2 citations

Erica N. Browne, Damian J. Denson, Emily Moore, Jackie Mungo, Noah Mancuso +6 more

Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metrics

medRxiv(2025)10.1101/2025.09.29.25336900
N/A
0DataRank · unranked
0 citations

Athena P. Kourtis, Yizhi Liang, Lijia Zheng, Teresa Puente, Ya-Lin A. Huang +8 more